BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH

Go back to BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
Techne Corp (NASDAQ: TECH) Delayed: 72.50 +0.02 (0.03%)
Previous Close $72.48    52 Week High $117.42 
Open $72.50    52 Week Low $79.95 
Day High $72.54    P/E 23.46 
Day Low $72.48    EPS $3.09 
Volume 1,544,825